Top Featured Companies Dominating the Pneumothorax Treatment Landscape.
- Medtronic
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Angiotech
- BetaGlue
- Teleflex Incorporated
- Abbott
- Smith’s Group plc
- ATMOS MedizinTechnik GmbH & Co. KG
- Sinapi Biomedical
- Nobelpharma Co., Ltd
- Vygon
Browse Key Market Insights with Data Illustration:
In the News
- 27 March 2024 - Medtronic plc (NYSE: MDT), a leading global supplier of medical technology, announced that the EvolutTM FX+ transcatheter aortic valve replacement (TAVR) system has received FDA approval in the US for the treatment of symptomatic severe aortic stenosis. The most recent Evolut FX+ TAVR system is intended to make coronary access easier while preserving the valve performance advantages of the previous Evolut TAVR platform.
- 31st January 2024 - The world leader in science-based nutrition, Abbott (NYSE: ABT), has announced the introduction of its new PROTALITYTM brand. The first product in this range to cater to the increasing number of adults who want to lose weight without sacrificing healthy nutrition and muscle mass is the high-protein nutrition smoothie.
